The enterosoluble vacant capsules from hypromellose has effectively 、 overcome the insufficiency of the molecular construction when protein encounters alcohols. Using its surface insufficiency it conducts an organic integration with the enteric coating. The product attains a still higher acid- resistance and more safety. Because it doesn’ t change the tenacity after wrapped, it is more convenient of the filling, storage and transportation.
The enterosoluble vacant capsules from hypromellose will greatly promote the development of the special content medicaments. It is a better choice for enterosoluble drugs in mass production rapidly. And also it is a low cost.